<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02964234</url>
  </required_header>
  <id_info>
    <org_study_id>2015-1246</org_study_id>
    <secondary_id>K01CA193918</secondary_id>
    <nct_id>NCT02964234</nct_id>
  </id_info>
  <brief_title>Empowering Latinas to Obtain Breast Cancer Screenings</brief_title>
  <official_title>Empowering Latinas to Obtain Breast Cancer Screenings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Resurrection Project</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Juan Diego Centro Comunitario</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The participatory-based project will quantify the 'added benefit' of an empowerment
      intervention relative to an education intervention for 150 Latinas on the following outcomes:
      women's adherence to breast cancer screening guidelines; women's psychosocial facilitators
      (self-efficacy, norms, support, and knowledge); and women's dissemination of breast health
      messages throughout their social network. The empowerment intervention will train Latinas in
      how to discuss breast health with their family and friends and volunteer in local breast
      health promotion programs. Academic, clinician, and community partners will work together
      throughout intervention development and evaluation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Latinas suffer disproportionately from breast cancer relative to non-Latina Whites (NLWs),
      including late stage detection. While there have been controversies in breast cancer
      screening, non-adherence to guideline-concordant screening continues to be a major modifiable
      determinant of breast cancer outcome disparities. Thus, increasing participation in breast
      cancer screening among Latinas, especially care that corresponds with clinical and academic
      guidelines, is a public health priority. Participatory approaches are popular methods to
      improve screening within this group and have included approaches that 1) deliver education to
      non-adherent Latinas and 2) train community health advocates (community health workers,
      breast cancer survivors) to engage in breast health promotion. The second approach
      (empowerment interventions) concerns training participants to engage in social outreach
      (e.g., having conversations with family and friends about breast health) and volunteering
      (e.g., helping in health fairs, engaging in civic campaigns about breast cancer programs).
      Patient activation and volunteerism literature suggest that empowerment interventions may
      have 'added value' for participants themselves over delivering education in terms of
      preventive health psychosocial factors and practices. Relative to education interventions,
      empowerment interventions may also affect women's networks, as they may be more likely to
      disseminate evidence-based breast health promotion among their family and friends. To date,
      little research has compared interventions' effects on individual-level outcomes or used
      formal social network analysis to examine network effects. The proposed work adds to the
      literature through empirically comparing two approaches (education versus empowerment) on
      three sets of outcomes: 1) women's own screening, 2) women's own self-efficacy, norms,
      support, knowledge; and 3) women's networks (measured by egocentric analysis). I will lead
      this work and will benefit from the collective expertise and resources of my mentors (Drs.
      Ferrans, Mermelstein, Geller) and collaborators (Dr. Schneider, The Resurrection Project,
      Metropolitan Chicago Breast Cancer Task Force, Sinai Urban Health Institute, University of
      Illinois Cancer Center). Aim 1 intervention development will be accomplished through
      continuous stakeholder engagement and specifically through meetings and focus groups with a
      bilingual, bicultural community advisory engagement board (CEAB), UICC radiologists and
      target participants (non-adherent Latinas). We have already begun this process and are
      obtaining formative data. After we develop intervention materials, a pilot trial will be
      conducted with an area-level treatment control group design in Chicago. Participants will be
      150 Latinas with no history of health volunteerism, residence in one of two targeted areas,
      and non-adherence to US Preventive Services Task Force screening guidelines. Aim 1
      intervention evaluation will involve an analysis to compare differences in receipt of a
      medical record-confirmed screening within six months of participating in the study. Aim 2
      will be an analysis to compare interventions' effects on self-efficacy, norms, support,
      knowledge across three time points - pre-intervention, immediately post-intervention, and six
      months post-intervention. Aim 3 will be a social network analysis, specifically egocentric,
      to compare interventions' effects on breast health, network size, and network density as well
      as will number of peers referred to the study.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Actual">July 24, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Have Obtained Breast Cancer Screening</measure>
    <time_frame>6 months</time_frame>
    <description>Receipt of mammogram based on medical records and self report within 6 months of baseline survey (Yes or No)</description>
  </primary_outcome>
  <other_outcome>
    <measure>Changes in Psychosocial Facilitators of Screening Survey Measures</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Total scores/ranges are used. No subscales used. Knowledge - 5 items (Williams et al., 2011). Range for the change scores (baseline to 6-months) is -5 to 5. Higher scores represent a better outcome.
Cultural beliefs - Ferrans cultural beliefs scale (Ferrans et al., 2007). Range for the change scores (baseline to 6-months) is -17 to 17. Higher scores represent a worse outcome.
Breast cancer-specific self-efficacy - Mammography-Specific Self-Efficacy Scale (Champion, Skinner, &amp; Menon, 2005). Range for the change scores (baseline to 6-months) is -26 to 26. Higher scores represent a better outcome.
Positive breast cancer screening norms - 6 items ( Molina et al., 2015). Range for the change scores (baseline to 6-months) is -12 to 12. Higher scores represent a better outcome.
Breast cancer supportive social network size questions comprised an 8-item version of Berkman-Syme index. Range for the change scores (baseline to 6-months) is -25 to 25. Higher scores represent a better outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Individuals to Whom Participants Exchanged Information About Breast Cancer Screening.</measure>
    <time_frame>6 months</time_frame>
    <description>This was an open-ended questionnaire, based on the Burt Social Network Instrument. Higher numbers represent better outcomes.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">145</enrollment>
  <condition>Breastcancer</condition>
  <condition>Breast Diseases</condition>
  <arm_group>
    <arm_group_label>Empowerment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Behavior: Empowerment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Behavior: Education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Empowerment</intervention_name>
    <description>Three group sessions (breast cancer education; communication; volunteerism) 1.5 hours 3 times across 3 weeks</description>
    <arm_group_label>Empowerment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education</intervention_name>
    <description>Three group sessions (breast cancer education; diet; physical activity) 1.5 hours 3 times across 3 weeks</description>
    <arm_group_label>Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 52-75 years old;

          -  Identification as Latina/Hispanic/Chicana female;

          -  Residence in Pilsen, Little Village, East Side or South Chicago;

          -  No history of health volunteerism;

          -  No history of breast cancer; and

          -  Lack of a mammogram within the last two years

        Exclusion Criteria:

          -  Not meeting all inclusion criteria;

          -  Women will be excluded if they participated in formative focus groups
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>52 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yamile Molina, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Resurrection Project</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Juan Diego Centro Comunitario</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 11, 2016</study_first_submitted>
  <study_first_submitted_qc>November 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2016</study_first_posted>
  <results_first_submitted>April 25, 2020</results_first_submitted>
  <results_first_submitted_qc>May 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 26, 2020</results_first_posted>
  <last_update_submitted>June 21, 2020</last_update_submitted>
  <last_update_submitted_qc>June 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Yamile Molina</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Mammography Screening</keyword>
  <keyword>Latinas</keyword>
  <keyword>Breast cancer disparities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Breast Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After major study findings have been accepted for publication, Dr. Molina will develop an anonymized data set (i.e., no personally identifiable information) available to qualified scientists upon request. Data will only be made available to scientists who complete a data-sharing agreement that indicates: 1) commitment to using the data only for research purposes and not to identify any individual participant; 2) commitment to securing data using appropriate computer technology; and 3) commitment to destroying or returning the data after analyses are completed.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will become available 6 months after publication of the primary outcome papers.</ipd_time_frame>
    <ipd_access_criteria>The study protocol will be shared upon reasonable request by interested researchers. IRB approval will be required before data are released.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 3, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT02964234/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 7, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT02964234/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Empowerment</title>
          <description>Behavior: Empowerment
Empowerment: Three group sessions (breast cancer education; communication; volunteerism) 1.5 hours 3 times across 3 weeks</description>
        </group>
        <group group_id="P2">
          <title>Education</title>
          <description>Behavior: Education
Education: Three group sessions (breast cancer education; diet; physical activity) 1.5 hours 3 times across 3 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Empowerment</title>
          <description>Behavior: Empowerment
Empowerment: Three group sessions (breast cancer education; communication; volunteerism) 1.5 hours 3 times across 3 weeks</description>
        </group>
        <group group_id="B2">
          <title>Education</title>
          <description>Behavior: Education
Education: Three group sessions (breast cancer education; diet; physical activity) 1.5 hours 3 times across 3 weeks</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="76"/>
            <count group_id="B2" value="69"/>
            <count group_id="B3" value="145"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.05" spread="6.29"/>
                    <measurement group_id="B2" value="61.28" spread="6.36"/>
                    <measurement group_id="B3" value="61.16" spread="6.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="145"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="145"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insurance</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mammogram 4+ years ago</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mammography intention within next year</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Have Obtained Breast Cancer Screening</title>
        <description>Receipt of mammogram based on medical records and self report within 6 months of baseline survey (Yes or No)</description>
        <time_frame>6 months</time_frame>
        <population>Complete case analysis used - only participants who were retained until 6 month follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Empowerment</title>
            <description>Behavior: Empowerment
Empowerment: Three group sessions (breast cancer education; communication; volunteerism) 1.5 hours 3 times across 3 weeks</description>
          </group>
          <group group_id="O2">
            <title>Education</title>
            <description>Behavior: Education
Education: Three group sessions (breast cancer education; diet; physical activity) 1.5 hours 3 times across 3 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Have Obtained Breast Cancer Screening</title>
          <description>Receipt of mammogram based on medical records and self report within 6 months of baseline survey (Yes or No)</description>
          <population>Complete case analysis used - only participants who were retained until 6 month follow-up.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We conducted logistic regressions, clustering by cohort, given both interventions used a group format, and adjusting for age, education, income, insurance status, baseline mammography history, and baseline mammography intention. The null hypothesis was there would be no study arm differences. A priori power analysis suggested that a sample size of 150, assuming alpha = .05, power = .80 would lead us to detect medium/large effects (OR = 2.8).</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.005</p_value>
            <p_value_desc>We clustered by cohort, given both interventions used a group format, and adjusted for age, socioeconomic status (education, income, insurance status) baseline mammography history, and baseline mammography intention.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>10.59</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.01</ci_lower_limit>
            <ci_upper_limit>56.31</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes in Psychosocial Facilitators of Screening Survey Measures</title>
        <description>Total scores/ranges are used. No subscales used. Knowledge - 5 items (Williams et al., 2011). Range for the change scores (baseline to 6-months) is -5 to 5. Higher scores represent a better outcome.
Cultural beliefs - Ferrans cultural beliefs scale (Ferrans et al., 2007). Range for the change scores (baseline to 6-months) is -17 to 17. Higher scores represent a worse outcome.
Breast cancer-specific self-efficacy - Mammography-Specific Self-Efficacy Scale (Champion, Skinner, &amp; Menon, 2005). Range for the change scores (baseline to 6-months) is -26 to 26. Higher scores represent a better outcome.
Positive breast cancer screening norms - 6 items ( Molina et al., 2015). Range for the change scores (baseline to 6-months) is -12 to 12. Higher scores represent a better outcome.
Breast cancer supportive social network size questions comprised an 8-item version of Berkman-Syme index. Range for the change scores (baseline to 6-months) is -25 to 25. Higher scores represent a better outcome.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>This is a complete case analysis for outcome data, with all available data being used for participants who completed the 6-month follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Empowerment</title>
            <description>Behavior: Empowerment
Empowerment: Three group sessions (breast cancer education; communication; volunteerism) 1.5 hours 3 times across 3 weeks</description>
          </group>
          <group group_id="O2">
            <title>Education</title>
            <description>Behavior: Education
Education: Three group sessions (breast cancer education; diet; physical activity) 1.5 hours 3 times across 3 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Psychosocial Facilitators of Screening Survey Measures</title>
          <description>Total scores/ranges are used. No subscales used. Knowledge - 5 items (Williams et al., 2011). Range for the change scores (baseline to 6-months) is -5 to 5. Higher scores represent a better outcome.
Cultural beliefs - Ferrans cultural beliefs scale (Ferrans et al., 2007). Range for the change scores (baseline to 6-months) is -17 to 17. Higher scores represent a worse outcome.
Breast cancer-specific self-efficacy - Mammography-Specific Self-Efficacy Scale (Champion, Skinner, &amp; Menon, 2005). Range for the change scores (baseline to 6-months) is -26 to 26. Higher scores represent a better outcome.
Positive breast cancer screening norms - 6 items ( Molina et al., 2015). Range for the change scores (baseline to 6-months) is -12 to 12. Higher scores represent a better outcome.
Breast cancer supportive social network size questions comprised an 8-item version of Berkman-Syme index. Range for the change scores (baseline to 6-months) is -25 to 25. Higher scores represent a better outcome.</description>
          <population>This is a complete case analysis for outcome data, with all available data being used for participants who completed the 6-month follow-up.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Knowledge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.98" spread="1.60"/>
                    <measurement group_id="O2" value="1.37" spread="1.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cultural Beliefs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.36" spread="2.94"/>
                    <measurement group_id="O2" value="-2.41" spread="3.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Self-Efficacy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.02" spread="4.67"/>
                    <measurement group_id="O2" value="-1.00" spread="5.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social Norms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="2.42"/>
                    <measurement group_id="O2" value="0.32" spread="2.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Supportive Network size</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" spread="4.66"/>
                    <measurement group_id="O2" value="5.85" spread="2.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analyses were conducted using GEE with an exchangeable correlation structure and a gamma distribution with log link. All models included study arm, time, and the study arm*time. Covariates included age, education, and mammography history. With 150 Latinas, alpha = 0.05, power = 0.80, ICC = 0.0-0.05, we expected to detect small/medium interaction effects.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Regression, Linear</method>
            <method_desc>With GEE. Models had exchangeable correlation structure, a gamma distribution, and log link.</method_desc>
            <param_type>Slope</param_type>
            <param_value>-0.19</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.34</ci_lower_limit>
            <ci_upper_limit>-0.04</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Individuals to Whom Participants Exchanged Information About Breast Cancer Screening.</title>
        <description>This was an open-ended questionnaire, based on the Burt Social Network Instrument. Higher numbers represent better outcomes.</description>
        <time_frame>6 months</time_frame>
        <population>Complete case analysis used, wherein we focus on participants who completed the 6-month follow-up surveys.</population>
        <group_list>
          <group group_id="O1">
            <title>Empowerment</title>
            <description>Behavior: Empowerment
Empowerment: Three group sessions (breast cancer education; communication; volunteerism) 1.5 hours 3 times across 3 weeks</description>
          </group>
          <group group_id="O2">
            <title>Education</title>
            <description>Behavior: Education
Education: Three group sessions (breast cancer education; diet; physical activity) 1.5 hours 3 times across 3 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Individuals to Whom Participants Exchanged Information About Breast Cancer Screening.</title>
          <description>This was an open-ended questionnaire, based on the Burt Social Network Instrument. Higher numbers represent better outcomes.</description>
          <population>Complete case analysis used, wherein we focus on participants who completed the 6-month follow-up surveys.</population>
          <units>family/friends engaged</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.27" spread="6.17"/>
                    <measurement group_id="O2" value="5.81" spread="12.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We used ordinal regression, given the non-normal distribution revealed by preliminary analyses. Analyses clustered by cohort and adjusted for age, SES (education, income, insurance), mammography history, mammography intention, and baseline supportive breast cancer social network size. Power analyses suggested that with 150 Latinas, alpha = .05, power = .80, we would be able to detect a small effect (Cohen's f = 0.05).</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Analyses clustered by cohort and adjusted for age, SES (education, income, insurance), mammography history, mammography intention, and baseline supportive breast cancer social network size.</p_value_desc>
            <method>Ordinal regression</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>6.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.82</ci_lower_limit>
            <ci_upper_limit>13.32</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data were collected for up to 6 months per participant.</time_frame>
      <desc>We used standard definitions of adverse and serious adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Empowerment</title>
          <description>Behavior: Empowerment
Empowerment: Three group sessions (breast cancer education; communication; volunteerism) 1.5 hours 3 times across 3 weeks</description>
        </group>
        <group group_id="E2">
          <title>Education</title>
          <description>Behavior: Education
Education: Three group sessions (breast cancer education; diet; physical activity) 1.5 hours 3 times across 3 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="69"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="69"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There are several limitations to this study, including a small sample, use of non-probability based sampling strategies, and non-randomization.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Yamile Molina</name_or_title>
      <organization>University of Illinois at Chicago</organization>
      <phone>312-355-2679</phone>
      <email>ymolin2@uic.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

